Study Evaluating Subjects With Distal Renal Tubular Acidosis

Summary

This is a phase 3, prospective, multicenter, randomized, double-blinded, placebo-controlled withdrawal study comparing the efficacy of ADV7103 versus placebo in preventing the development of metabolic acidosis in pediatric and adult subjects with primary Distal Renal Tubular Acidosis (dRTA).

Timeline

Start

2021-09-20

Primary completion

2023-12-20

Completion

2023-12-20

Outcome

Outcome not reported

Stopped (Enrollment): “COVID-19 pandemic negatively impacted the ability to enroll patients.”

Drugs

Indications